Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures
- PMID: 34211312
- PMCID: PMC8240849
- DOI: 10.2147/SAR.S305972
Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures
Abstract
Introduction: The need for innovative approaches to address the opioid epidemic in the United States is widely recognized. Many challenges exist to addressing this epidemic, including the obstacles outpatient substance use treatment practices face in implementing measurement-based care (MBC), quality measurement systems, and evidence-based treatments. Also, there are insufficient opportunities for clinicians in these settings to participate in research, resulting in diminished translation of research findings into community-based practice. To address these challenges, the Addiction Medicine Practice-Based Research Network (AMNet) was developed to facilitate the uptake of MBC in outpatient practices via implementation of patient-reported assessments and quality of care performance measures to improve patient outcomes. This network will offer clinicians in outpatient settings (not incuding opioid treatment programs [OTPs]) the opportunity to participate in future substance use disorder treatment research studies.
Methods: A key step in the development of AMNet was the selection of substance use-specific assessment tools and quality of care performance measures for incorporation into the American Psychiatric Association's mental health patient registry, PsychPRO. A scoping review and multi-step consensus-based process were used to identify, review and select candidate assessment tools and quality of care performance measures for opioid use disorders (OUD) and substance use disorders (SUD).
Results: Following a consensus-based methodology, 12 standardized assessment tools and 3 quality of care performance measures for OUD and SUD were selected to help facilitate the implementation of MBC and quality improvement for AMNet participants. These tools were further categorized as core and optional.
Conclusion: By offering a collection of carefully vetted assessment tools and quality measures through PsychPRO, AMNet will help participating clinicians with the systematic uptake of MBC and delivery of evidence-based treatment for patients with SUD. Also, AMNet will act as a centralized repository of data collected from patients and clinicians in non-OTP outpatient addiction medicine practices and serve as a platform for opioid treatment research.
Keywords: addiction medicine; measurement-based care; patient-reported outcome measures; quality improvement; quality measures.
© 2021 Clarke et al.
Conflict of interest statement
Dr. Clarke serves on the Mental Health Landscape Project Advisory Panel for RAND Corporation: a project funded by Otsuka Pharmaceuticals that is not related to the present paper. Dr. Clarke reports grants, non-financial support from National Institute on Drug Abuse (NIDA), Agency for Healthcare Research and Quality, and Health and Human Services Center for Medicare and Medicaid Services (CMS) during the conduct of the study. Dr. Schwartz reports providing consultation to Verily Life Sciences, grants from NIDA, during the conduct of the study. He is PI of a NIDA-funded study that is receiving free medication from Indivior and Alkermes. Dr. Vocci reports receiving free medication from Alkermes and Braeburn Pharma for clinical studies. Dr. Vocci has also received meals from Braeburn Pharma. Dr. Vocci has consulted with and received meals and travel reimbursements from Lyndra Pharmaceuticals and Takeda Pharmaceuticals and a group of generic buprenorphine manufacturers. Dr. Vocci also received meals and travel reimbursement from Intratab Labs. Ms Ibrahim reports non-financial grant support from NIDA during the conduct of the study. Dr. Doty reports non-financial grant support from NIDA and CMS during the conduct of the study. Ms Patel reports non-financial grant support from NIDA during the conduct of the study. Ms Thompson reports non-financial grant support from NIDA and CMS during the conduct of the study.
Figures
Similar articles
-
Addiction Medicine Practice-Based Research Network (AMNet): Building Partnerships.Psychiatr Serv. 2021 Jul 1;72(7):845-847. doi: 10.1176/appi.ps.202000390. Epub 2021 Apr 15. Psychiatr Serv. 2021. PMID: 33853378 Free PMC article.
-
Experience Starting an Addiction Medicine Practice-based Research Network.J Addict Med. 2024 Nov-Dec 01;18(6):689-695. doi: 10.1097/ADM.0000000000001354. Epub 2024 Jul 30. J Addict Med. 2024. PMID: 39078061 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Using Measurement-Based Care as a Precision Medicine Strategy for Substance Use Disorders.Curr Psychiatry Rep. 2024 May;26(5):215-221. doi: 10.1007/s11920-024-01495-3. Epub 2024 Mar 15. Curr Psychiatry Rep. 2024. PMID: 38489141 Review.
-
Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Final Report [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Jun. Report No.: 21(22)-EHC032. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Jun. Report No.: 21(22)-EHC032. PMID: 35834618 Free Books & Documents. Review.
Cited by
-
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study.Addiction. 2022 Sep;117(9):2438-2447. doi: 10.1111/add.15875. Epub 2022 Apr 25. Addiction. 2022. PMID: 35293064 Free PMC article.
-
The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinic.Hepatol Commun. 2025 Feb 10;9(2):e0603. doi: 10.1097/HC9.0000000000000603. eCollection 2025 Feb 1. Hepatol Commun. 2025. PMID: 39927894 Free PMC article.
-
Longitudinal associations between pain and substance use disorder treatment outcomes.J Subst Abuse Treat. 2022 Dec;143:108892. doi: 10.1016/j.jsat.2022.108892. Epub 2022 Oct 1. J Subst Abuse Treat. 2022. PMID: 36228338 Free PMC article.
-
Towards shortening the Brief Addiction Monitor-Revised (BAM-R).Drug Alcohol Depend Rep. 2023 Aug 6;8:100183. doi: 10.1016/j.dadr.2023.100183. eCollection 2023 Sep. Drug Alcohol Depend Rep. 2023. PMID: 37637231 Free PMC article.
-
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.Addict Sci Clin Pract. 2024 Feb 28;19(1):14. doi: 10.1186/s13722-024-00446-w. Addict Sci Clin Pract. 2024. PMID: 38419116 Free PMC article.
References
-
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services; 2020. Administration. Available from: https://www.samhsa.gov/data/. Accessed May27, 2021.
Grants and funding
LinkOut - more resources
Full Text Sources